Minnelide is an effective therapy against pancreatic cancer. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants. Minnelide reduced tumor volume in multiple models of pancreatic cancer. Minnelide was a more effective drug against pancreatic cancer models. It effectively reduced tumor burden and tumor related morbidity in different unique but complementary mouse models. It reduced metastatic spread and increased survival in the different models as well.
Molecular Weight:
470.41
CAS Number:
[1254885-39-6]
Formula:
C21H27O10P
Target:
Apoptosis|||Others
T71113
* VAT and and shipping costs not included. Errors and price changes excepted
